Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
MeiraGTx
Biotech
Hologen AI commits $430M to MeiraGTx Parkinson's gene therapy
Hologen AI has committed up to $430 million in a multifaceted agreement to help take MeiraGTx’s Parkinson’s gene therapy all the way to market.
James Waldron
Mar 13, 2025 10:51am
MeiraGTx gene therapy allows 11 blind children to see
Feb 21, 2025 10:50am
MeiraGTx Parkinson's gene therapy boosts motor function in ph. 2
Oct 15, 2024 7:00am
MeiraGTx gifts last of gene therapy rights to J&J for $415M
Dec 21, 2023 10:14am
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 1:06pm
MeiraGTx gene therapy for ALS rescues deficits in rodents
Oct 29, 2023 3:50pm